1. Market Research
  2. > Biotechnology Market Trends
  3. > Analyzing the Global Market for Active Pharmaceutical Ingredients

Analyzing the Global Market for Active Pharmaceutical Ingredients

  • September 2014
  • -
  • Aruvian's R'search
  • -
  • 455 pages

Summary

Table of Contents

Search Inside

The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the end of 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market.

The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.

Aruvian Research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expiries of blockbuster drugs and the impact of the economic recession on the market.

An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.

An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.

An analysis of the market for APIs in North America is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in North America and the impacts on the industry. Key markets analyzed in North America include Canada and the United States.

An analysis of the major industry players such as Teva, Albemarle, Actavis, Boehringer, Cipla and others is carried out through an analysis of their business profile, major products & services, financial analysis and a SWOT analysis. This in-depth report on the global market for Active Pharmaceutical Ingredients from Aruvian Research is a comprehensive profile of this industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 202

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 202

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, ...

High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User - Forecast to 2021

High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User - Forecast to 2021

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global high throughput process development market is expected to reach USD 19.78 billion in 2021 from USD 9.91 billion in 2016, at a CAGR of 14.8% from 2016 to 2021. Growth in the high throughput process ...

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-development deals ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.